2025 Platelet Transfusion Thresholds: When to Transfuse and When Not to Transfuse – Chokri Ben Lamine
Chokri Ben Lamine, Assistant Consultant at King Faisal Specialist Hospital and Research Center, shared a post on X about a recent article by Ryan A. Metcalf et al., published in JAMA, adding:
”2025 AABB/ICTMG Platelet Transfusion Thresholds
Nonbleeding chemotherapy / allo-HSCT: transfuse if platelet count is less than 10 × 10⁹/L
Adult critical illness, no major bleeding: transfuse if platelet count is less than 10 × 10⁹/L
Lumbar puncture: transfuse if platelet count is less than 20 × 10⁹/L
CVC insertion at compressible site (IJ/femoral): transfuse if platelet count is less than 10 × 10⁹/L
Interventional radiology:
- Low-risk procedure: transfuse if platelet count is less than 20 × 10⁹/L
- High-risk procedure: transfuse if platelet count is less than 50 × 10⁹/L
- Major non-neuraxial surgery: transfuse if platelet count is less than 50 × 10⁹/L
- Preterm neonate without major bleeding: transfuse if platelet count is less than 25 × 10⁹/L
Autologous SCT or aplastic anemia, nonbleeding adults: routine prophylactic transfusion not recommended
Dengue without major bleeding: platelet transfusion not recommended
Nonoperative ICH with platelet count greater than 100 × 10⁹/L, including antiplatelet use: platelet transfusion is not recommended.
Central-line removal is not specifically addressed; the threshold of less than 10 × 10⁹/L applies to insertion at compressible sites, not to removal.
Clinical bleeding, coagulopathy, medications, catheter site/type, and ability to apply compression should guide removal.
Platelet Transfusion – JAMA 2025.pdf. ”
Title: 2025 AABB and ICTMG International Clinical Practice Guidelines
Authors:Ryan A. Metcalf, Susan Nahirniak, Gordon Guyatt, Aarti Bathla, Sandra K. White, Arwa Z. Al-Riyami, Rachel C. Jug, Ursula La Rocca, Jeannie L. Callum, Claudia S. Cohn, Abe DeAnda, Robert A. DeSimone, Allan Dubon, Lise J. Estcourt, Daniela C. Filipescu, Mark K. Fung, Ruchika Goel, Aaron S. Hess, Heather A. Hume, Richard M. Kaufman, Peter Kranke, Vernon J. Louw, Morten H. Møller, Michael F. Murphy, Jennifer A. Muszynski, Cian J. O’Kelly, Monica B. Pagano, Gopal K. Patidar, Katerina Pavenski, Jacqueline N. Poston, Nabiha H. Saifee, Moritz Stolla, Zbigniew M. Szczepiorkowski, Aaron A. R. Tobian, Raman Uberoi, Jonathan Waters, Brittney Williams, Erica M. Wood, Nicole D. Zantek, Michelle P. Zeller, Brenda J. Grossman, Simon J. Stanworth.

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?